Esophageal Cancer-Derived Extracellular Vesicle miR-21-5p Contributes to EMT of ESCC Cells by Disorganizing Macrophage Polarization

Esophageal Cancer-Derived Extracellular Vesicle miR-21-5p Contributes to EMT of ESCC Cells by Disorganizing Macrophage Polarization

The disorganized polarization of tumor-associated macrophages (TAMs) exerts a critical effect on tumor progression. MicroRNAs (miRNAs) in extracellular vesicles (EVs) secreted from cancer cells may contribute to this process. However, the relationship between TAMs and EVs-miRNAs-mediated regulation...

Full description

Bibliographic Details
Main Authors:	Jing Song, Peiyan Yang, Xiuwen Li, Xinyi Zhu, Mengxin Liu, Xuexin Duan, Ran Liu
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Cancers
Subjects:	esophageal squamous cell carcinoma (ESCC) EVs-miR-21-5p macrophage polarization epithelial-mesenchymal transition
Online Access:	https://www.mdpi.com/2072-6694/13/16/4122

Similar Items

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)
by: Qi Song, et al.
Published: (2021-09-01)

Hsa_circ_0043603 promotes the progression of esophageal squamous cell carcinoma by sponging miR-1178–3p and regulating AADAC expression
by: Xuezhong Wang, et al.
Published: (2023-09-01)

Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights
by: Stavros P. Papadakos, et al.
Published: (2024-03-01)

SPI1-Mediated Upregulation of the CST1 Gene as an Independent Poor Prognostic Factor Accelerates Metastasis in Esophageal Squamous Cell Carcinoma (ESCC) by Interacting with MMP2
by: Fei-Fei Luo, et al.
Published: (2023-09-01)

Extracellular shuttling miR‐21 contributes to esophageal cancers and human umbilical vein endothelial cell communication in the tumor microenvironment and promotes tumor angiogenesis by targeting phosphatase and tensinhomolog
by: Shanbo Zheng, et al.
Published: (2023-11-01)

Clinical value of station 4R node dissection in esophageal squamous cell carcinoma
by: Xin-ye Wang, et al.
Published: (2023-12-01)

Global research trend of esophageal squamous cell carcinoma from 2012 to 2022: a bibliometric analysis
by: Zehua Zhang, et al.
Published: (2022-08-01)

Editorial: Roles of microbes in esophageal disease
by: Learn-Han Lee, et al.
Published: (2023-11-01)

Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer
by: Zhe Zhang, et al.
Published: (2023-04-01)

Abdominal lymph node metastasis in non-surgical esophageal squamous cell carcinoma: prognostic significance and a novel staging strategy
by: Zongxing Zhao, et al.
Published: (2023-10-01)

Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1
by: Lanfang Jiang, et al.
Published: (2017-06-01)

Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial
by: Yong Li, et al.
Published: (2023-03-01)

PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancer
by: Ruisha Tu, et al.
Published: (2023-12-01)

Drug repositioning for esophageal squamous cell carcinoma
by: Adam N. Bennett, et al.
Published: (2022-09-01)

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
by: Chengzhi Ding, et al.
Published: (2023-12-01)

High Mitochondrial DNA Copy Number and Bioenergetic Function Are Associated with Tumor Invasion of Esophageal Squamous Cell Carcinoma Cell Lines
by: Liang-Shun Wang, et al.
Published: (2012-09-01)

Identifying LATS2 as a prognostic biomarker relevant to immune infiltrates in human esophageal squamous cell carcinoma
by: Minqi Zhu, et al.
Published: (2022-09-01)

Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry
by: Xiaobin Cui, et al.
Published: (2017-08-01)

AURKA knockdown inhibits esophageal squamous cell carcinoma progression through ferroptosis
by: Yuan Mi, et al.
Published: (2024-04-01)

Identification of Cancer Stem Cell Molecular Markers and Effects of hsa-miR-21-3p on Stemness in Esophageal Squamous Cell Carcinoma
by: Zhikui Gao, et al.
Published: (2019-04-01)

Long non-coding RNA PCAT5 regulates the progression of Esophageal Squamous Cell Carcinoma via miR-4295/PHF20
by: Hui Liu, et al.
Published: (2023-12-01)

FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation
by: Yunzhi Pan, et al.
Published: (2023-03-01)

Antisense lncRNA PCNA-AS1 promotes esophageal squamous cell carcinoma progression through the miR-2467-3p/PCNA axis
by: Hu Tao, et al.
Published: (2022-09-01)

Pretreatment plasma fibrinogen and serum albumin levels predict therapeutic efficacy of concurrent radiochemotherapy for esophageal squamous cell cancer
by: Jijin Wang, et al.
Published: (2022-10-01)

Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report
by: Yanhong Yao, et al.
Published: (2022-02-01)

Prognostic value of the combined preoperative plasma fibrinogen and systemic inflammatory indexes in ESCC patients
by: Honggang Cao, et al.
Published: (2023-08-01)

High TLR6 Expression Status Predicts a More Favorable Prognosis after Esophagectomy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
by: Yusuke Sato, et al.
Published: (2023-05-01)

Predictive value of the presence of Prevotella and the ratio of Porphyromonas gingivalis to Prevotella in saliva for esophageal squamous cell carcinoma
by: Xiaohui Chen, et al.
Published: (2022-10-01)

Association of mitochondrial DNA mutations with Chinese esophageal squamous cell carcinomas (ESCC) by analyzing the whole mitochondrial DNA genomes
by: Qiang Ji, et al.
Published: (2019-01-01)

DEPDC1B collaborates with GABRD to regulate ESCC progression
by: Yunfeng Yuan, et al.
Published: (2022-06-01)

Investigation of the Potential Presence of Porphyromonas gingivalis in Esophageal Squamous Cell Carcinoma (ESCC) Paraffin Embedded Tissue Samples
by: Afsoon Taghavi, et al.
Published: (2023-11-01)

Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy
by: Zhanpeng Tang, et al.
Published: (2022-07-01)

Long non‐coding RNA ESCCAL‐1/miR‐590/LRP6 signaling pathway participates in the progression of esophageal squamous cell carcinoma
by: Hongya Guan, et al.
Published: (2023-01-01)

SAA1 regulated by S1P/S1PR1 promotes the progression of ESCC via β-catenin activation
by: Qianqian Li, et al.
Published: (2024-03-01)

Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy
by: Chia-Hsin Lin, et al.
Published: (2020-03-01)

IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis
by: Chang Wang, et al.
Published: (2022-12-01)

PABPC1-induced stabilization of IFI27 mRNA promotes angiogenesis and malignant progression in esophageal squamous cell carcinoma through exosomal miRNA-21-5p
by: Ying Zhang, et al.
Published: (2022-03-01)

SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain
by: Yanqun Liu, et al.
Published: (2022-12-01)

Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma
by: Bohao Zheng, et al.
Published: (2023-02-01)

Upregulation of PAX2 Promotes the Metastasis of Esophageal Cancer through Interleukin-5
by: Pengfei Liu, et al.
Published: (2015-01-01)